US 11097017
Gadolinium-based contrast agents for sensitive detection of Zn2+with MRI
granted A61KA61K49/106A61K49/108
Quick answer
US patent 11097017 (Gadolinium-based contrast agents for sensitive detection of Zn2+with MRI) held by The Board of Regents of the University of Texas System expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K49/106, A61K49/108